✦ LIBER ✦

Experimental study on inhibitory effects of histone deacetylase inhibitor MS-275 and TSA on bladder cancer cells

✍ Scribed by Wei Qu; Yin-dong Kang; Mei-sheng Zhou; Li-li Fu; Zhen-hao Hua; Li-ming Wang

Book ID: 116956459
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 895 KB
Volume: 28
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2008.11.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of histone deacetylase inhibitors

Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells

✍ Giovanni Di Bernardo; Nicola Alessio; Carmela Dell'Aversana; Fiorina Casale; Dia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

## Abstract Histone deacetylase inhibitors (HDACis) have received considerable attention for their anti‐tumoral properties. We report here the effects of two HDACis, SAHA and MS‐275, on the biology of mesenchymal stem cells (MSCs). It is well known that HDACis trigger both DNA damage responses and

1157 STUDY ON THE SYNERGIC EFFECT AND ME

1157 STUDY ON THE SYNERGIC EFFECT AND MECHANISM OF THE HISTONE-DEACETYLASE INHIBITOR, TRICHOSTATIN A AND GEMCITABINE IN BLADDER CANCER CELL LINES

✍ Jeon, Hwang Gyun; Yoon, Cheol Yong; Park, Mi Jeong; Jeong, Chang Wook; Jeong, Se 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 78 KB

The histone deacetylase inhibitors depsi

The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells

✍ Kasman, L; Lu, P; Voelkel-Johnson, C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 402 KB

Histone deacetylase inhibitor augments a

Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells

✍ Shuichi Iwahashi; Mitsuo Shimada; Tohru Utsunomiya; Yuji Morine; Satoru Imura; T 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 395 KB

Antiproliferative effects of the histone

Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines

✍ Junji Tsurutani; Hiroshi Soda; Mikio Oka; Mitsuhiro Suenaga; Seiji Doi; Yoichi N 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 248 KB 👁 1 views

## Abstract FR901228 is a novel histone deacetylase (HDAC) inhibitor, and its antiproliferative effects on non‐small cell lung cancer cells have been shown __in vitro__. However, there have been no reports concerning the effects on small‐cell lung cancer (SCLC). We have recently demonstrated that t

Effect of histone deacetylase inhibitors

Effect of histone deacetylase inhibitors on the cell nucleus and nucleolus of leukemic myeloblasts in vitro – A cytochemical study

✍ K Smetana; M. Zápotocký; J. Starková; J. Trka 📂 Article 📅 2007 🏛 Elsevier Science 🌐 German ⚖ 478 KB